LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | +125.0% | 100 | +185.7% | 0.00% | – |
| Q1 2022 | $4,000 | -96.3% | 35 | -95.0% | 0.00% | -100.0% |
| Q4 2021 | $108,000 | +12.5% | 702 | +2.3% | 0.00% | 0.0% |
| Q3 2021 | $96,000 | +20.0% | 686 | +12.8% | 0.00% | +100.0% |
| Q2 2021 | $80,000 | -99.9% | 608 | +29.4% | 0.00% | 0.0% |
| Q1 2021 | $71,652,000 | +597000.0% | 470 | +295.0% | 0.00% | – |
| Q4 2020 | $12,000 | +9.1% | 119 | 0.0% | 0.00% | – |
| Q3 2020 | $11,000 | -15.4% | 119 | 0.0% | 0.00% | – |
| Q2 2020 | $13,000 | +62.5% | 119 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | -33.3% | 119 | -0.8% | 0.00% | – |
| Q4 2019 | $12,000 | +9.1% | 120 | +0.8% | 0.00% | – |
| Q3 2019 | $11,000 | +22.2% | 119 | +41.7% | 0.00% | – |
| Q2 2019 | $9,000 | -77.5% | 84 | -41.7% | 0.00% | -100.0% |
| Q3 2018 | $40,000 | +135.3% | 144 | +71.4% | 0.00% | +100.0% |
| Q2 2018 | $17,000 | +30.8% | 84 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $13,000 | +333.3% | 84 | +180.0% | 0.00% | – |
| Q2 2017 | $3,000 | +50.0% | 30 | +20.0% | 0.00% | – |
| Q1 2017 | $2,000 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |